MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia
Hanqian L. Carlson, Thai T Nguyen, Samantha Tauchmann, Sarah A. Carratt, Traci L. Kruer, Nana Adjoa Ben-Crentsil, Maria E. Balasis, Hyeyoon Kim, Chia‐Feng Tsai, Tao Liu, Shawn B. Shrestha, Jared Michael Fischer, Eric Padron, Theodore P. Braun, Julia E. Maxson
This study identifies MYST acetyltransferases as therapeutic targets in SETBP1-mutant leukemia, showing that MYST inhibitors reduce target gene expression and improve survival in mouse models.
bioRxiv · Jan 8, 2026 · PreprintCancer Biology